Influenza vaccination in elderly patients with advanced colorectal cancer

Journal of Clinical Oncology

Volumn 21, Issue 6, 2003, Pages 1161-1166

  Earle, Craig C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; ELDERLY CARE; HEALTH CARE COST; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; PHYSICIAN; PNEUMONIA; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SOCIOECONOMICS; CANCER REGISTRY; COLORECTAL TUMOR; FEMALE; MALE; MEDICAID; MEDICARE; PATHOLOGY; PHYSICIAN ATTITUDE; UNITED STATES;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MEDICAID; MEDICARE; PHYSICIAN'S ROLE; SEER PROGRAM; UNITED STATES;

EID: 0037445115     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.06.008     Document Type: Article

References (39)

1. Nichol KL: Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 161:749-759, 2001
2. Bridges CB, Fukada K, Cox NJ, et al: Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 50:1-44, 2001
3. Ahmed F, Singleton JA, Franks AL: Influenza vaccination for healthy young adults. N Engl J Med 345:1543-1547, 2001
4. Simonsen L, Fukada K, Schonberger LB, et al: The impact of influenza epidemics on hospitalizations. J Infect Dis 181:831-837, 2000
5. Keech M, Scott AJ, Ryan PJ: The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med (Lond) 48:85-90, 1998
6. Centers for Disease Control: Weekly surveillance report, week 7, 2002. Http://www.cdc.gov/ncidod/diseases/flu/weeklyarchives/weekly07.htm
7. Centers for Disease Control: Weekly surveillance report, week 9, 2002. Http://www.cdc.gov/ncidod/diseases/flu/weeklyarchives/weekly09.htm
8. Ortbals DW, Liebhaber H, Presant CA, et al: Influenza immunization of adult patients with malignant diseases. Ann Intern Med 87:552-557, 1977
9. Centers for Disease Control: National Immunization Program, 2002. Http://www.cdc.gov/nip/flu
10. Brydak LB, Machala M: Humoral immune response to influenza vaccination in patients from high risk groups. Drugs 60:35-53, 2000
11. Brydak LB, Guzy J, Starzyk J, et al: Humoral immune response after vaccination against influenza in patients with breast cancer. Support Care Cancer 9:65-68, 2001
12. Andersen H, Petrie K, Berrisford C, et al: Seroconversion after influenza vaccination in patients with lung cancer. Br J Cancer 80:219-220, 1999
13. Shildt RA, Luedke DW, Kasai G, et al: Antibody response to influenza immunization in adult patients with malignant disease. Cancer 44:1629-1635, 1979
14. Ganz PA, Shanley JD, Cherry JD: Responses of patients with neoplastic diseases to influenza virus vaccine. Cancer 42:2244-2247, 1978
15. Schafer AI, Churchill WH, Ames P, et al: The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine. Cancer 43:25-30, 1979
16. Gross PA, Gould AL, Brown AE: Effect of cancer chemotherapy on the immune response to influenza virus vaccine: Review of published studies. Rev Infect Dis 7:613-618, 1985
17. Gross PA, Lee H, Wolff JA, et al: Influenza immunization in immunosuppressed children. J Pediatr 92:30-35, 1978
18. Zippin C, Lum D, Hankey BF: Completeness of hospital cancer case reporting from the SEER program of the National Cancer Institute. Cancer 76:2343-2350, 1995
19. Nattinger AB, McAuliffe TL, Schapira MM: Generalizability of the surveillance, epidemiology, and end results registry population: Factors relevant to epidemiologic and health care research. J Clin Epidemiol 50:939-945, 1997
20. Ries LAG, Kosary CL, Hankey BF, et al: SEER Cancer Statistics Review, 1973-1994. Bethesda, MD, National Cancer Institute, NIH publication 97-2789, 1997
21. Potosky AL, Riley GF, Lubitz JD, et al: Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31:732-748, 1993
22. Brown ML, Riley GF, Schussler N, et al: Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 40:IV104-IV117, 2002(suppl)
23. Riley GF, Potosky AL, Lubitz JD, et al: Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care 33:828-841, 1995
24. Bach PB, Guadagnoli E, Schrag D, et al: Patient demographic and socioeconomic characteristics in the SEER-Medicare database. Med Care 40:IV19-IV25, 2002 (suppl)
25. Krieger N: Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Public Health 82:703-710, 1992
26. Deyo RA, Gherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
27. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
28. Klabunde CN: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000
29. Earle CC, Tsai JS, Gelber RD, et al: Effectiveness of palliative chemotherapy for advanced lung cancer: Instrumental variable and propensity analysis. J Clin Oncol 19:1064-1070, 2001
30. Nichol KL, Margolis KL, Wouremna J, et al: Effectiveness of influenza vaccine in the elderly. Gerontology 42:274-279, 1996
31. Barker WH, Mullooly JP: Pneumonia and influenza deaths during epidemics: Implications for prevention. Arch Intern Med 142:85-89, 1982
32. Centers for Disease Control: Influenza and pneumococcal vaccination levels among persons aged ≥ 65 years: United States, 1999. MMWR Morb Mortal Wkly Rep 50:532-537, 2001
33. Schneider EC, Cleary PD, Zaslavsky AM, et al: Racial disparity in influenza vaccination: Does managed care narrow the gap between African Americans and whites? J Am Med Assoc 286:1455-1460, 2001
34. Stiver HG, Weinerman BH: Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients. Can Med Assoc J 119:733-738, 1978
35. Brown AE: Influenza and pneumococcal immunization of patients with neoplastic diseases. Schweiz Med Wochenschr Suppl 113:30-34, 1983 (suppl)
36. Lamont EB, Lauderdale DS, Schilsky RL, et al: Construct validity of Medicare chemotherapy claims. Med Care 40:201-211, 2002
37. Final results: Medicare influenza vaccine demonstration-Selected states, 1988-1992. MMWR Morb Mortal Wkly Rep 42:601-604, 1993
38. Husereau DR, Brady B, McGeer A: An assessment of oseltamivir for the treatment of suspected influenza: Canadian Coordinating Office for Health Technology Assessment Technology overview no. 7. Canadian Coordinating Office for Health Technology Assessment Technology, Ottawa, Ontario, Canada, 2002
39. Barker WH, Mullooly JP: Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 112:798-811, 1980